======= SOX10 ======= == Gene Information == * **Official Symbol**: SOX10 * **Official Name**: SRY-box transcription factor 10 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6663|6663]] * **UniProt**: [[https://www.uniprot.org/uniprot/P56693|P56693]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SOX10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SOX10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602229|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional activator after forming a protein complex with other proteins. This protein acts as a nucleocytoplasmic shuttle protein and is important for neural crest and peripheral nervous system development. Mutations in this gene are associated with Waardenburg-Shah and Waardenburg-Hirschsprung disease. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Transcription factor that plays a central role in developing and mature glia. Specifically activates expression of myelin genes, during oligodendrocyte (OL) maturation, such as DUSP15 and MYRF, thereby playing a central role in oligodendrocyte maturation and CNS myelination. Once induced, MYRF cooperates with SOX10 to implement the myelination program. Transcriptional activator of MITF, acting synergistically with PAX3 (PubMed:21965087). {ECO:0000250|UniProtKB:Q04888, ECO:0000269|PubMed:21965087}. |Sox N| |HMG box| |extrinsic component of mitochondrial outer membrane| |cellular response to progesterone stimulus| |regulation of Schwann cell proliferation| |negative regulation of Schwann cell proliferation| |lacrimal gland development| |enteric nervous system development| |negative regulation of glial cell proliferation| |positive regulation of myelination| |central nervous system myelination| |axon ensheathment in central nervous system| |melanocyte differentiation| |positive regulation of neuroblast proliferation| |regulation of glial cell proliferation| |pigment cell differentiation| |regulation of neuroblast proliferation| |positive regulation of stem cell proliferation| |developmental pigmentation| |negative regulation of gliogenesis| |oligodendrocyte development| |regulation of myelination| |exocrine system development| |response to progesterone| |autonomic nervous system development| |digestive tract morphogenesis| |promoter-specific chromatin binding| |positive regulation of neural precursor cell proliferation| |neural crest cell migration| |positive regulation of nervous system process| |regulation of stem cell proliferation| |oligodendrocyte differentiation| |positive regulation of gliogenesis| |peripheral nervous system development| |transcription elongation from RNA polymerase II promoter| |neural crest cell development| |mesenchymal cell development| |stem cell development| |regulation of neural precursor cell proliferation| |neural crest cell differentiation| |DNA-templated transcription, elongation| |cellular response to ketone| |pigmentation| |RNA polymerase II distal enhancer sequence-specific DNA binding| |myelination| |glial cell development| |ensheathment of neurons| |axon ensheathment| |chromatin| |regulation of gliogenesis| |digestive tract development| |regulation of nervous system process| |digestive system development| |mesenchymal cell differentiation| |stem cell differentiation| |cell maturation| |morphogenesis of a branching epithelium| |morphogenesis of a branching structure| |glial cell differentiation| |ameboidal-type cell migration| |negative regulation of canonical Wnt signaling pathway| |cellular response to steroid hormone stimulus| |response to ketone| |negative regulation of Wnt signaling pathway| |gliogenesis| |mesenchyme development| |developmental maturation| |regulation of canonical Wnt signaling pathway| |transcription coactivator activity| |negative regulation of neurogenesis| |negative regulation of nervous system development| |response to steroid hormone| |transcription factor binding| |negative regulation of cell development| |regulation of Wnt signaling pathway| |in utero embryonic development| |developmental growth| |growth| |cellular response to drug| |gland development| |morphogenesis of an epithelium| |DNA-binding transcription activator activity, RNA polymerase II-specific| |positive regulation of neurogenesis| |transcription by RNA polymerase II| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to lipid| |positive regulation of nervous system development| |cellular response to organic cyclic compound| |positive regulation of cell development| |tissue morphogenesis| |regulation of system process| |cellular response to hormone stimulus| |chordate embryonic development| |transcription, DNA-templated| |nucleic acid-templated transcription| |embryo development ending in birth or egg hatching| |RNA biosynthetic process| |tube morphogenesis| |DNA-binding transcription factor activity| |negative regulation of cell population proliferation| |negative regulation of cell differentiation| |regulation of neurogenesis| |tube development| |response to lipid| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |response to hormone| |positive regulation of cell population proliferation| |response to organic cyclic compound| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |cell migration| |positive regulation of cell differentiation| |embryo development| |central nervous system development| |negative regulation of cell death| |response to drug| |cellular response to oxygen-containing compound| |identical protein binding| |localization of cell| |cell motility| |nucleobase-containing compound biosynthetic process| |epithelium development| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |organic cyclic compound biosynthetic process| |locomotion| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |generation of neurons| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |movement of cell or subcellular component| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |RNA metabolic process| |regulation of cell death| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|1.76| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 41/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|1/26| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|16/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3522 * **Expression level (log2 read counts)**: -2.79 {{:chemogenomics:nalm6 dist.png?nolink |}}